Aktiia has been validated in multiple clinical trials and received CE Mark clearance for users aged 21-85, excluding contraindications due to certain health conditions. Please refer to the user manual for a complete list of contraindications.

Aktiia is in the process of conducting additional research to expand our intended user population, including testing the product with diabetics.